MPM BioImpact LLC

MPM BioImpact LLC is an Investment Adviser institutional filer with the SEC under CIK 1687078, reporting 37 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

• State of incorporation: DE
• Filing type: 13F-HR
• Latest reporting period: 2026-06-30
• Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in MPM BioImpact LLC's most recent 13F filing, ranked by reported market value.

1. Cullinan Therapeutics, Inc. (CGEM)
2. Aktis Oncology, Inc. (AKTS)
3. Liquidia Corporation (LQDA)
4. Revolution Medicines, Inc. (RVMD)
5. Corcept Therapeutics, Inc. (CORT)
6. Edgewise Therapeutics Inc (EWTX)
7. Travere Therapeutics Inc (TVTX)
8. DBV Technologies S A (DBVT)
9. Trevi Therapeutics Inc (TRVI)
10. Alumis Inc (ALMS)